Clinical trials: Living Donor Liver Transplantation Recipients, open to volunteers
Chronic Liver Disease
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration in Adult Living Donor Liver Transplant (LDLT) Recipients.
This placebo controlled randomized control study aims to analyze the effect of UDCA supplementation on liver regeneration in Living Donor Liver Transplant (LDLT) recipients.
- Trial name
- NCT07664020
- Testing
- Ursodeoxycholic acid, Standard Medical Treatment
- Where
- India
- Volunteers
- 130 people
- Sponsor
- Institute of Liver and Biliary Sciences, India
Living Donor Liver Transplantation Recipients, Deceased Donor Liver Transplantation Recipients
Longitudinal Follow-up and Health-Related Outcomes in Liver Transplant Recipients and Living Donors
This prospective cohort study aims to identify risk factors for postoperative adverse events in liver transplant recipients and living donors.
- Conditions
- Living Donor Liver Transplantation Recipients, Deceased Donor Liver Transplantation Recipients, Living Liver Donor
- Trial name
- NCT07301853
- Testing
- liver transplantation, Living Donor Hepatectomy
- Where
- China
- Volunteers
- 9,999 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine